These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1384 related items for PubMed ID: 26861596
1. Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress sindrome. Fanelli V, Ranieri MV, Mancebo J, Moerer O, Quintel M, Morley S, Moran I, Parrilla F, Costamagna A, Gaudiosi M, Combes A. Crit Care; 2016 Feb 10; 20():36. PubMed ID: 26861596 [Abstract] [Full Text] [Related]
2. Feasibility and safety of low-flow extracorporeal CO2 removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Schmidt M, Jaber S, Zogheib E, Godet T, Capellier G, Combes A. Crit Care; 2018 May 10; 22(1):122. PubMed ID: 29743094 [Abstract] [Full Text] [Related]
3. Feasibility and safety of ultra-low tidal volume ventilation without extracorporeal circulation in moderately severe and severe ARDS patients. Richard JC, Marque S, Gros A, Muller M, Prat G, Beduneau G, Quenot JP, Dellamonica J, Tapponnier R, Soum E, Bitker L, Richecoeur J, REVA research network. Intensive Care Med; 2019 Nov 10; 45(11):1590-1598. PubMed ID: 31549225 [Abstract] [Full Text] [Related]
4. Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Combes A, Fanelli V, Pham T, Ranieri VM, European Society of Intensive Care Medicine Trials Group and the “Strategy of Ultra-Protective lung ventilation with Extracorporeal CO2 Removal for New-Onset moderate to severe ARDS” (SUPERNOVA) investigators. Intensive Care Med; 2019 May 10; 45(5):592-600. PubMed ID: 30790030 [Abstract] [Full Text] [Related]
5. Low flow extracorporeal CO2 removal in ARDS patients: a prospective short-term crossover pilot study. Peperstraete H, Eloot S, Depuydt P, De Somer F, Roosens C, Hoste E. BMC Anesthesiol; 2017 Nov 28; 17(1):155. PubMed ID: 29179681 [Abstract] [Full Text] [Related]
6. Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials. Guérin C, Papazian L, Reignier J, Ayzac L, Loundou A, Forel JM, investigators of the Acurasys and Proseva trials. Crit Care; 2016 Nov 29; 20(1):384. PubMed ID: 27894328 [Abstract] [Full Text] [Related]
7. Venovenous extracorporeal CO2 removal to support ultraprotective ventilation in moderate-severe acute respiratory distress syndrome: A systematic review and meta-analysis of the literature. Worku E, Brodie D, Ling RR, Ramanathan K, Combes A, Shekar K. Perfusion; 2023 Jul 29; 38(5):1062-1079. PubMed ID: 35656595 [Abstract] [Full Text] [Related]
8. Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design. Goligher EC, Combes A, Brodie D, Ferguson ND, Pesenti AM, Ranieri VM, Slutsky AS, SUPERNOVA investigators (European Society of Intensive Care Medicine trials group) and for the International ECMO Network (ECMONet). Intensive Care Med; 2019 Sep 29; 45(9):1219-1230. PubMed ID: 31432216 [Abstract] [Full Text] [Related]
9. Volume-controlled ventilation and pressure-controlled inverse ratio ventilation: a comparison of their effects in ARDS patients. Mancebo J, Vallverdú I, Bak E, Domínguez G, Subirana M, Benito S, Net A. Monaldi Arch Chest Dis; 1994 Jun 29; 49(3):201-7. PubMed ID: 8087114 [Abstract] [Full Text] [Related]
10. [Extracorporeal membrane oxygenation for acute respiratory distress syndrome caused by acute phosgene poisoning: a report of 4 cases]. He Z, Yang X, Yang C. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb 29; 31(2):232-235. PubMed ID: 30827316 [Abstract] [Full Text] [Related]
12. The impacts of baseline ventilator parameters on hospital mortality in acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation: a retrospective cohort study. Wu MY, Chang YS, Huang CC, Wu TI, Lin PJ. BMC Pulm Med; 2017 Dec 08; 17(1):181. PubMed ID: 29221484 [Abstract] [Full Text] [Related]
13. Long term feasibility of ultraprotective lung ventilation with low-flow extracorporeal carbon dioxide removal in ARDS patients. Chiumello D, Pozzi T, Mereto E, Fratti I, Chiodaroli E, Gattinoni L, Coppola S. J Crit Care; 2022 Oct 08; 71():154092. PubMed ID: 35714453 [Abstract] [Full Text] [Related]
14. Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study. Allardet-Servent J, Castanier M, Signouret T, Soundaravelou R, Lepidi A, Seghboyan JM. Crit Care Med; 2015 Dec 08; 43(12):2570-81. PubMed ID: 26488219 [Abstract] [Full Text] [Related]
15. Effects of ultraprotective ventilation, extracorporeal carbon dioxide removal, and spontaneous breathing on lung morphofunction and inflammation in experimental severe acute respiratory distress syndrome. Güldner A, Kiss T, Bluth T, Uhlig C, Braune A, Carvalho N, Quast T, Rentzsch I, Huhle R, Spieth P, Richter T, Saddy F, Rocco PR, Kasper M, Koch T, Pelosi P, de Abreu MG. Anesthesiology; 2015 Mar 08; 122(3):631-46. PubMed ID: 25371037 [Abstract] [Full Text] [Related]
17. Respiratory and haemodynamic effects of conventional volume controlled PEEP ventilation, pressure regulated volume controlled ventilation and low frequency positive pressure ventilation with extracorporeal carbon dioxide removal in pigs with acute ARDS. Kesecioglu J, Telci L, Esen F, Akpir K, Tütüncü AS, Denkel T, Erdmann W, Lachmann B. Acta Anaesthesiol Scand; 1994 Nov 08; 38(8):879-84. PubMed ID: 7887114 [Abstract] [Full Text] [Related]
18. Should we use driving pressure to set tidal volume? Grieco DL, Chen L, Dres M, Brochard L. Curr Opin Crit Care; 2017 Feb 08; 23(1):38-44. PubMed ID: 27875410 [Abstract] [Full Text] [Related]